Iris Kamer
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
- Oncology 16
- Cancer-related Molecular Pathways 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
- Cancer Cells and Metastasis 3
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- Co-authors
- Hagar Kalinski (2 shared papers)Paz Einat (2 shared papers)Ayelet Chajut (2 shared papers)Rami Skaliter (2 shared papers)Andrei V. Budanov (2 shared papers)Alexander Faerman (2 shared papers)Elena Feinstein (2 shared papers)Svetlana Gorodin (2 shared papers)
- Journals
- Nature Cancer (4 papers)PLoS ONE (3 papers)Molecular Cancer Research (2 papers)Archives of Environmental Contamination and Toxicology (2 papers)Cancer Immunology Research (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Iris Kamer
34 papers receiving 4.0k citations
Iris Kamer's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 1.3k
- Biotechnology 441
- Cancer Research 583
- Molecular Biology 2.2k
- Immunology 612
Countries citing papers authored by Iris Kamer
This map shows the geographic impact of Iris Kamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kamer more than expected).
Fields of papers citing papers by Iris Kamer
This network shows the impact of papers produced by Iris Kamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kamer. The network helps show where Iris Kamer may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Kamer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The human tumor microbiome is composed of tumor type–specific intracellular bacteria Hit paper breakdown → | 2020 | 1840 |
| 2 | 2002 | 497 | |
| 3 | 2002 | 324 | |
| 4 | 2005 | 190 | |
| 5 | 2022 | 146 | |
| 6 | 2010 | 134 | |
| 7 | 2010 | 132 | |
| 8 | 2015 | 120 | |
| 9 | Interferon-stimulated neutrophils as a predictor of immunotherapy response Hit paper breakdown → | 2024 | 104 |
| 10 | 2011 | 97 | |
| 11 | 2009 | 59 | |
| 12 | 2002 | 49 | |
| 13 | 2019 | 47 | |
| 14 | 2022 | 36 | |
| 15 | 2022 | 35 | |
| 16 | 2013 | 34 | |
| 17 | 2023 | 25 | |
| 18 | 2020 | 25 | |
| 19 | 2003 | 24 | |
| 20 | 2020 | 22 |
About Iris Kamer
Iris Kamer is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis, having authored 35 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers), Cancer Cells and Metastasis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (1.3k citations), Biotechnology (441 citations), Cancer Research (583 citations), Molecular Biology (2.2k citations) and Immunology (612 citations). Iris Kamer has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Hagar Kalinski, Paz Einat, Ayelet Chajut, Rami Skaliter, Andrei V. Budanov, Alexander Faerman, Elena Feinstein, Svetlana Gorodin, Tzipora Shoshani and Elena Zelin. Their work appears in journals such as Nature Cancer, PLoS ONE, Molecular Cancer Research, Archives of Environmental Contamination and Toxicology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.